

PharMetrics Plus is already a trusted source of data across the pharmaceutical industry, supporting a wide range of analytical projects within all phases of development and commercialization. Now enhanced with mortality data, PharMetrics Plus can answer a multitude of critical questions for HEOR leaders and other researchers by combining mortality information with IQVIA's comprehensive real-world data on commercially insured patients. The data includes views into diagnoses, treatments, and associated costs, backed by the most complete source of U.S. mortality data on the market (90% of U.S. deaths compared to official CDC reporting).
We empower life sciences with connected intelligence, transforming data into actionable insights for smarter decisions and better patient outcomes.